Related Experiment Video
Updated: Jun 16, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release
Denise Bechet1, Loraine Tirand, Béatrice Faivre
1Centre de Recherche en Automatique de Nancy (CRAN), Nancy-University, CNRS, Centre Alexis Vautrin, Avenue de Bourgogne, Brabois, 54511, Vandoeuvre-lès-Nancy, France.
Purpose:
This article characterizes the vascular effects following vascular-targeted photodynamic therapy with a photosensitizer which actively targets endothelial cells.
Methods:
This strategy was considered by coupling a chlorin to a heptapeptide targeting neuropilin-1 in human malignant glioma-bearing nude mice. A laser Doppler microvascular perfusion monitor was used to monitor microvascular blood perfusion in tumor tissue. Endothelial cells' ultra structural integrity was observed by transmission electron microscopy. The consequences of photosensitization on tumor vessels, tissue factor expression, fibrinogen consumption, and thrombogenic effects were studied by immunohistochemical staining.
Results:
Treatment of glioma-bearing mice with the conjugate showed a statistically significant tumor growth delay. Vascular effect was characterized by a decrease in tumor tissue blood flow at about 50% baseline during treatment not related to variations in temperature. This vascular shutdown was mediated by tumor blood vessels' congestion. A pro-thrombotic behavior of targeted endothelial cells in the absence of ultra structural changes led to the induction of tissue factor expression from the earliest times post-treatment. Expression of tissue factor-initiated thrombi formation was also related to an increase in fibrinogen consumption.
Conclusion:
Using a peptide-conjugated photosensitizer targeting neuropilin-1, induction of tissue factor expression immediately post-treatment, led to the establishment of thrombogenic effects within the vessel lumen.
Insights
Vascular-targeted photodynamic therapy using a peptide-conjugated photosensitizer effectively delayed glioma growth by inducing blood vessel congestion and pro-thrombotic effects in endothelial cells.
Area of Science:
- Oncology
- Vascular Biology
- Photodynamic Therapy
Background:
- Photodynamic therapy (PDT) is an emerging cancer treatment.
- Targeting endothelial cells offers a strategy to disrupt tumor vasculature.
Purpose of the Study:
- To characterize the vascular effects of a novel photosensitizer targeting endothelial cells.
- To evaluate the therapeutic efficacy of this vascular-targeted PDT in glioma models.
Main Methods:
- A chlorin-based photosensitizer was conjugated to a neuropilin-1 targeting heptapeptide.
- Tumor microvascular perfusion was monitored using laser Doppler.
- Endothelial cell integrity was assessed via transmission electron microscopy.
- Immunohistochemistry evaluated tissue factor expression and thrombotic effects.
Main Results:
- The conjugate significantly delayed glioma tumor growth in mice.
- A ~50% reduction in tumor blood flow was observed, attributed to vascular congestion.
- Targeted endothelial cells exhibited pro-thrombotic behavior and induced tissue factor expression.
- Thrombi formation and fibrinogen consumption were observed post-treatment.
Conclusions:
- Peptide-conjugated photosensitizers can effectively target tumor vasculature.
- Neuropilin-1 targeting induces tissue factor expression and thrombotic effects.
- This strategy offers a promising approach for vascular-disrupting cancer therapy.
Related Concept Videos
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

